BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2670399)

  • 1. Management of apnea in infants.
    Kriter KE; Blanchard J
    Clin Pharm; 1989 Aug; 8(8):577-87. PubMed ID: 2670399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylxanthines in apnea of prematurity.
    Aranda JV; Turmen T
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy.
    Ment LR; Scott DT; Ehrenkranz RA; Duncan CC
    Am J Perinatol; 1985 Jul; 2(3):223-7. PubMed ID: 4015773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apnea of prematurity: theophylline v. caffeine.
    Harrison H
    Alaska Med; 1992; 34(4):173-6. PubMed ID: 1288312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma beta-endorphin concentration and xanthine treatment in apnea of prematurity.
    Sankaran K; Hindmarsh KW; Tan L; Kalapurackal M
    Clin Invest Med; 1993 Jun; 16(3):197-203. PubMed ID: 8365047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: The use of xanthines in treating apnea of prematurity.
    Kuzemko JA
    Pediatrics; 1976 Feb; 57(2):293. PubMed ID: 1250669
    [No Abstract]   [Full Text] [Related]  

  • 12. Theophylline or caffeine: which is best for apnea of prematurity?
    Gannon BA
    Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine for apnea of prematurity: a neonatal success story.
    Kreutzer K; Bassler D
    Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: The use of xanthines in treating apnea of prematurity.
    Morens DM
    Pediatrics; 1975 Oct; 56(4):617-9. PubMed ID: 1165973
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity.
    Al-Saif S; Alvaro R; Manfreda J; Kwiatkowski K; Cates D; Qurashi M; Rigatto H
    J Pediatr; 2008 Oct; 153(4):513-8. PubMed ID: 18534618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The choice between theophylline and caffeine in the treatment of apnea in premature infants].
    Bairam A; Boutroy MJ; Badonnel Y; Vert P
    Arch Fr Pediatr; 1990; 47(6):461-5. PubMed ID: 2206108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug treatment of apnoea in premature infants (author's transl)].
    Willard D; Mack G; Messer J; Klethi J
    Nouv Presse Med; 1981 Mar; 10(14):1143-5. PubMed ID: 6111783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence-based methylxanthine use in the NICU.
    Spitzer AR
    Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.